Free Trial

Damora Therapeutics, Inc. Common Stock (DMRA) Earnings Date, Estimates & Call Transcripts

Damora Therapeutics, Inc. Common Stock logo
$24.60 +0.72 (+3.02%)
As of 05/15/2026 04:00 PM Eastern

Damora Therapeutics, Inc. Common Stock Earnings Summary

Damora Therapeutics, Inc. Common Stock released Q1 2026 earnings on May 12, 2026, reporting an EPS of -$0.62, which missed analysts' consensus estimates of -$0.39 by $0.23. With a trailing EPS of -$6.88, Damora Therapeutics, Inc. Common Stock's earnings are expected to decrease next year, from ($0.95) to ($1.36) per share.

Upcoming Q2
Earnings Date
Aug. 5Before Market OpensEstimated
Consensus EPS
(May. 12)
-$0.39
Actual EPS
(May. 12)
-$0.62 Missed By -$0.23

Q1 2026 Earnings Resources

DMRA Upcoming Earnings

Damora Therapeutics, Inc. Common Stock's next earnings date is estimated for Wednesday, August 5, 2026, based on past reporting schedules.

Get Damora Therapeutics, Inc. Common Stock Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Damora Therapeutics, Inc. Common Stock and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

DMRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Damora Therapeutics, Inc. Common Stock Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.95) EPS
Next Year EPS Consensus Estimate
($1.36) EPS

Damora Therapeutics, Inc. Common Stock Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2026
(Estimated)
--------
5/12/2026Q1 2026-$0.3878-$0.62 -$0.2322-$0.62--
11/6/2025Q3 2025--$2.36--$2.36--
8/5/2025Q2 2025--$2.60--$2.60--
5/8/2025Q1 2025--$1.92--$1.92--
3/19/2025Q4 2024-$3.12-$5.22 -$2.10-$5.22--
8/12/2024--$8.00-$4.00+$4.00-$0.12--

Data powered by Fiscal.ai.

Damora Therapeutics, Inc. Common Stock Earnings - Frequently Asked Questions

Damora Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 5th, 2026 based off last year's report dates. Learn more on DMRA's earnings history.

In the previous quarter, Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) missed the analysts' consensus estimate of ($0.39) by $0.23 with a reported earnings per share (EPS) of ($0.62). Learn more on analysts' earnings estimate vs. DMRA's actual earnings.

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) has a recorded net income of -$209.84 million. DMRA has generated -$6.88 earnings per share over the last four quarters.

Damora Therapeutics, Inc. Common Stock's earnings are expected to decrease from ($0.95) per share to ($1.36) per share in the next year.


This page (NASDAQ:DMRA) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners